CMS

CMS’ Proposed DIR Fee Reform Garners Industry Support

CMS’ Proposed DIR Fee Reform Garners Industry Support

The latest effort from the Centers for Medicare and Medicaid Services is garnering industry attention. CMS on Tuesday unveiled a proposed rule, titled “Modernizing Part D and Medicare Advantage to Lower Drug Prices and Reduce Out-of-Pocket Expenses,” which includes provisions focused on direct and indirect remuneration, or DIR, fee reform.

How to Become a Mutual Drug Member

Learn More